{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:06:48Z","timestamp":1779944808679,"version":"3.53.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease (CKD) and end-stage renal disease in type 2 diabetes mellitus (T2DM) patients. Recent studies have demonstrated that pregnancy zone protein (PZP), a hepatic cytokine, plays a role in regulating glucose and lipid metabolism. This retrospective study aimed to investigate the connection between plasma PZP concentrations and DKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>All participants were stratified by estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR). The discovery cohort included 130 participants, from whom plasma samples were collected for four-dimensional data-independent acquisition (4D-DIA) quantitative proteomics. In contrast, plasma PZP concentrations were measured using the enzyme-linked immunosorbent assay (ELISA) in a validation cohort of 283 participants. Comparisons of clinical parameters, Spearman\u2019s rho correlation analysis, logistic regression, and receiver operating characteristic (ROC) curve analysis were performed. Data were retrieved from public databases, and plasma PZP expression was simultaneously assessed in db\/db mice and in primary hepatocytes treated with high glucose and palmitic acid (HGPA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>4D-DIA quantitative proteomics identified PZP as a differentially expressed protein in DKD patients. In the validation cohort, plasma PZP levels were significantly increased in DKD patients. Spearman\u2019s rho correlation analysis revealed positive correlations between plasma PZP concentrations and systolic blood pressure (SBP), HbA1c, low-density lipoprotein (LDL), Cr, blood urea nitrogen (BUN), and UACR, as well as negative correlations with high-density lipoprotein (HDL) and eGFR. A multiple logistic regression analysis demonstrated a significant correlation between PZP and DKD progression (mild DKD: OR\u202f=\u202f1.007; severe DKD: OR\u202f=\u202f1.011). The ROC curve area was 0.8143. Plasma PZP levels in db\/db mice were notably elevated, and a positive correlation with the UACR was observed. Moreover, PZP mRNA expression in HGPA-treated primary hepatocytes was twice as high as that in untreated cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In summary, elevated plasma PZP levels are independently associated with DKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1833221","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:54:17Z","timestamp":1779944057000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma PZP level elevation: a potential correlate of diabetic kidney disease progression"],"prefix":"10.3389","volume":"13","author":[{"given":"Lin","family":"Mao","sequence":"first","affiliation":[{"name":"Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Artificial Intelligence and Cell-based Medical Engineering for Interdisciplinary Innovation and Clinical Translation","place":["Beijing, China"]},{"name":"Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Yin","sequence":"additional","affiliation":[{"name":"Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Artificial Intelligence and Cell-based Medical Engineering for Interdisciplinary Innovation and Clinical Translation","place":["Beijing, China"]},{"name":"Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyan","family":"Yang","sequence":"additional","affiliation":[{"name":"Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Artificial Intelligence and Cell-based Medical Engineering for Interdisciplinary Innovation and Clinical Translation","place":["Beijing, China"]},{"name":"Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Artificial Intelligence and Cell-based Medical Engineering for Interdisciplinary Innovation and Clinical Translation","place":["Beijing, China"]},{"name":"Laboratory for Clinical Medicine, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014","volume":"316","author":"Afkarian","year":"2016","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"ref3","volume-title":"IDF Diabetes Atlas, Diabetes and Kidney Disease","year":"2023"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/nep.13860","article-title":"Update on diagnosis, pathophysiology, and management of diabetic kidney disease","volume":"26","author":"Sugahara","year":"2021","journal-title":"Nephrology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14007","article-title":"An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines","volume":"22","author":"Selby","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2025.109037","article-title":"Growth differentiation factor-15: a marker for diabetic kidney disease in patients with metabolic-associated fatty liver disease","volume":"39","author":"Shora","year":"2025","journal-title":"J Diabetes Complicat"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1080\/21691401.2019.1649274","article-title":"Knockdown of ANGPTL-4 inhibits inflammatory response and extracellular matrix accumulation in glomerular mesangial cells cultured under high glucose condition","volume":"47","author":"Qin","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4093\/dmj.2018.0235","article-title":"Fibroblast growth factor 21 attenuates diabetes-induced renal fibrosis by negatively regulating TGF-\u03b2-p53-Smad2\/3-mediated epithelial-to-mesenchymal transition via activation of AKT","volume":"44","author":"Lin","year":"2020","journal-title":"Diabetes Metab J"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.eprac.2021.02.004","article-title":"Association between non-alcoholic fatty liver disease and diabetes-related microvascular complications: a retrospective cross-sectional study of hospitalized patients","volume":"28","author":"Wen","year":"2022","journal-title":"Endocr Pract"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1032814","DOI":"10.3389\/fendo.2022.1032814","article-title":"Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy","volume":"13","author":"Yan","year":"2022","journal-title":"Front Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0167-4781(91)90157-H","article-title":"Primary structure of pregnancy zone protein. Molecular cloning of a full-length PZP cDNA clone by the polymerase chain reaction","volume":"1088","author":"Devriendt","year":"1991","journal-title":"Biochimica et Biophysica Acta"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"103149","DOI":"10.1016\/j.jri.2020.103149","article-title":"Spliceosome protein EFTUD2 is upregulated in the trophoblast of spontaneous miscarriage and hydatidiform mole","volume":"140","author":"L\u00f6b","year":"2020","journal-title":"J Reprod Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.mce.2005.10.004","article-title":"Functions of alpha 2 macroglobulins in pregnancy","volume":"245","author":"Tayade","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cellimm.2005.03.007","article-title":"Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production","volume":"232","author":"Skornicka","year":"2004","journal-title":"Cell Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"149013","DOI":"10.1016\/j.gene.2024.149013","article-title":"Pregnancy zone protein, a potential research target in multiple diseases","volume":"935","author":"Wu","year":"2025","journal-title":"Gene"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/15598276211037964","article-title":"Maternal cardiovascular disease after pre-eclampsia and gestational hypertension: a narrative review","volume":"17","author":"Oliver-Williams","year":"2021","journal-title":"Am J Lifestyle Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"100794","DOI":"10.1016\/j.ajogmf.2022.100794","article-title":"Serum amyloid A1 and pregnancy zone protein in pregnancy complications and correlation with markers of placental dysfunction","volume":"5","author":"Fosheim","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/mnfr.201100081","article-title":"Mechanisms of weight maintenance under high- and low-protein, low-glycaemic index diets","volume":"55","author":"Rubio-Aliaga","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"950619","DOI":"10.3389\/fphys.2022.950619","article-title":"Overexpression of pregnancy zone protein in fat antagonizes diet-induced obesity under an intermittent fasting regime","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Physiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e2101991","DOI":"10.1002\/advs.202101991","article-title":"Hepatokine pregnancy zone protein governs the diet-induced thermogenesis through activating brown adipose tissue","volume":"8","author":"Lin","year":"2021","journal-title":"Adv Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e70015","DOI":"10.1002\/jgm.70015","article-title":"Integrated single-cell transcriptome and eQTL analyses reveal the role of PZP in aging and chronic kidney disease","volume":"27","author":"Huang","year":"2025","journal-title":"J Gene Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"116952","DOI":"10.1016\/j.biopha.2024.116952","article-title":"Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways","volume":"177","author":"Yong","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2012.09.010","article-title":"Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria","volume":"151","author":"Fedorenko","year":"2012","journal-title":"Cell"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/abbi.2001.2659","article-title":"Differential binding properties of human pregnancy zone protein\u2013 and \u03b12-macroglobulin\u2013proteinase complexes to low-density lipoprotein receptor-related protein","volume":"398","author":"Chiabrando","year":"2002","journal-title":"Arch Biochem Biophys"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3724\/abbs.2025034","article-title":"Melatonin attenuates kidney injury by alleviating lysosomal damage in diabetic kidney disease","volume":"57","author":"Chen","year":"2025","journal-title":"Acta Biochim Biophys Sin"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"154405","DOI":"10.1016\/j.metabol.2020.154405","article-title":"Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy","volume":"113","author":"Otomo","year":"2020","journal-title":"Metabolism"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e0213127","DOI":"10.1371\/journal.pone.0213127","article-title":"Participation of the SMAD2\/3 signalling pathway in the down regulation of megalin\/LRP2 by transforming growth factor beta (TGF-\u00df1)","volume":"14","author":"Ahmad","year":"2019","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"F625","DOI":"10.1152\/ajprenal.00152.2003","article-title":"Smad expression during kidney development","volume":"286","author":"Vrljicak","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"153323","DOI":"10.1016\/j.phymed.2020.153323","article-title":"Novel poricoic acids attenuate renal fibrosis through regulating redox signalling and aryl hydrocarbon receptor activation","volume":"79","author":"Wang","year":"2020","journal-title":"Phytomedicine"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.3390\/jcm12185894","article-title":"Pregnancy zone protein as an emerging biomarker for cardiovascular risk in pediatric chronic kidney disease","volume":"12","author":"Chen","year":"2023","journal-title":"J Clin Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1833221\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:54:28Z","timestamp":1779944068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1833221\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":31,"alternative-id":["10.3389\/fmed.2026.1833221"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1833221","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1833221"}}